ArticleAmerican journal of cancer research2022

Different classes of antibiotics exhibit disparate negative impacts on the therapeutic efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients.

Hui Qiu et al.PubMed ↗Full text ↗

No numbers read from the abstract.